479 related articles for article (PubMed ID: 27742410)
1. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP
Hung KC; Huang HJ; Wang YT; Lin AM
J Ethnopharmacol; 2016 Dec; 194():522-529. PubMed ID: 27742410
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of Baicalein on Acrolein-induced Neurotoxicity in the Nigrostriatal Dopaminergic System of Rat Brain.
Zhao WZ; Wang HT; Huang HJ; Lo YL; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):130-137. PubMed ID: 28866823
[TBL] [Abstract][Full Text] [Related]
3. Roles of autophagy in MPP+-induced neurotoxicity in vivo: the involvement of mitochondria and α-synuclein aggregation.
Hung KC; Huang HJ; Lin MW; Lei YP; Lin AM
PLoS One; 2014; 9(3):e91074. PubMed ID: 24646838
[TBL] [Abstract][Full Text] [Related]
4. Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death.
Wang YT; Lin HC; Zhao WZ; Huang HJ; Lo YL; Wang HT; Lin AM
Sci Rep; 2017 Apr; 7():45741. PubMed ID: 28401906
[TBL] [Abstract][Full Text] [Related]
5. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
6. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
[TBL] [Abstract][Full Text] [Related]
7. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
Jung UJ; Jeon MT; Choi MS; Kim SR
J Med Food; 2014 May; 17(5):599-605. PubMed ID: 24660866
[TBL] [Abstract][Full Text] [Related]
8. Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease.
Leem E; Nam JH; Jeon MT; Shin WH; Won SY; Park SJ; Choi MS; Jin BK; Jung UJ; Kim SR
J Nutr Biochem; 2014 Jul; 25(7):801-6. PubMed ID: 24797334
[TBL] [Abstract][Full Text] [Related]
9. Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis.
Liu YL; Hsu CC; Huang HJ; Chang CJ; Sun SH; Lin AM
Mol Neurobiol; 2020 Jan; 57(1):96-104. PubMed ID: 31832973
[TBL] [Abstract][Full Text] [Related]
10. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.
Chen ST; Chuang JI; Hong MH; Li EI
J Pineal Res; 2002 May; 32(4):262-9. PubMed ID: 11982797
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
[TBL] [Abstract][Full Text] [Related]
13. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
Han J; Cheng FC; Yang Z; Dryhurst G
J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein.
Lin AM; Fang SF; Chao PL; Yang CH
J Pineal Res; 2007 Sep; 43(2):163-71. PubMed ID: 17645694
[TBL] [Abstract][Full Text] [Related]
16. Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
Gao JP; Sun S; Li WW; Chen YP; Cai DF
Neurosci Bull; 2008 Jun; 24(3):133-42. PubMed ID: 18500385
[TBL] [Abstract][Full Text] [Related]
17. Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats.
Banerjee R; Saravanan KS; Thomas B; Sindhu KM; Mohanakumar KP
Neurochem Res; 2008 Jun; 33(6):985-95. PubMed ID: 17763941
[TBL] [Abstract][Full Text] [Related]
18. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons.
Li FQ; Wang T; Pei Z; Liu B; Hong JS
J Neural Transm (Vienna); 2005 Mar; 112(3):331-47. PubMed ID: 15503194
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.
Banerjee R; Sreetama S; Saravanan KS; Dey SN; Mohanakumar KP
Neurochem Res; 2007 Jul; 32(7):1238-47. PubMed ID: 17401660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
